Search results
Transposons could be new targets for aging research and treatment
Medical Xpress· 1 day agoThe study, "An eQTL-based approach reveals candidate regulators of LINE-1 RNA levels in lymphoblastoid cells," was published in PLOS Genetics on June 7, 2024. Transposons ...
Signs of Alzheimer’s were everywhere. Then his brain improved
CNN via Yahoo News· 6 hours agoThe trial is designed to uncover cognitive risk factors and counter them with a personalized plan of...
Removing skin cancer with Mohs surgery
Medical Xpress· 3 hours agoSkin cancer is the most common form of cancer. Mohs surgery is one of the most successful surgical treatments for removing skin cancer. The abnormal...
Researchers discover promising approach to prevent recurrence of breast cancer
Medical Xpress· 22 hours agoA particular challenge in breast cancer treatment is the recurrence of the disease. The reasons why dormant breast cancer cells awake even after several years are not well understood. A Finnish ...
...Receives BARDA Project NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's...
NewMediaWire via Yahoo Finance· 5 hours ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen,...
Mouse study suggests cancer drug could be used to target protein connection that spurs Parkinson's...
Medical Xpress· 23 hours agoThe findings, published May 31 in Nature Communications, reveal how Aplp1 connects with Lag3, another cell surface receptor, in a key part of a process that helps spread harmful ...
Roche (RHHBY) Reports Upbeat Data on Columvi From STARGLO Study
Zacks via Yahoo Finance· 1 day agoRoche's (RHHBY) Columvi significantly extends survival in patients with relapsed or refractory...
Fasting primes the immune system's natural killer cells to better fight cancer, new study in mice...
Medical Xpress· 4 days agoInstitute and their collaborators have shown for the first time that fasting can reprogram the metabolism of natural killer cells, helping them to survive in the harsh environment in and around ...
Secondary Tumors After CAR-T Cancer Therapies Are Rare: Study
WFMZ Eastern Pennsylvania and Western New Jersey· 5 days agoCAR-T cell therapy to treat blood cancers is safer than previously thought, with little risk that...
CAR-T cell therapy to treat blood cancers unlikely to increase risk of secondary cancers
UPI· 5 days agoA study of more than 700 patients treated at Stanford University found that the risk of secondary...